Abstract
There is an urgent and unmet need to develop effective vaccines to reduce the global burden of infectious disease in both animals and humans, and in particular for the majority of pathogens that infect via mucosal sites. Here we summarise the impediments to developing mucosal vaccines and review the new and emerging technologies aimed at overcoming the lack of effective vaccine delivery systems that is the major obstacle to developing new mucosal vaccines.
| Original language | English |
|---|---|
| Pages (from-to) | 205-214 |
| Number of pages | 10 |
| Journal | Clinical and Experimental Immunology |
| Volume | 196 |
| Issue number | 2 |
| Early online date | 8 Apr 2019 |
| DOIs | |
| Publication status | Published - 1 May 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- bacterial
- mucosal
- vaccines
- viral
Profiles
-
Simon Carding
- Norwich Medical School - Research Leader
- Norwich Institute for Healthy Aging - Member
- Metabolic Health - Member
- Gastroenterology and Gut Biology - Member
Person: Research Group Member, Research Centre Member, Academic, Teaching and Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver